Siga Technologies Inc
SIGA Nasdaq Pharmaceutical Preparations Financials FY2016โFY2025
Last close ยท Oct 23, 2026
$3.12
1.0%What Siga Technologies Inc does
No business description yet.
- Legal name
- SIGA TECHNOLOGIES INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Mar 10, 2026
- Accession ยท CIK
- 0001437749-26-007557
0001010086
Revenue and margins
Siga Technologies Inc had $94.6M of revenue in fiscal 2025, down 31.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ in fiscal 2025, โ of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Siga Technologies Inc returned $43.1M to shareholders in fiscal 2025. The diluted share count fell 0.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Siga Technologies Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $103M | $98.8M | $150M | $155M | $155M |
| Current ratio | 6.8x | 8.6x | 4.4x | 9.1x | 11.8x |
| Quick ratio | 6.2x | 6.8x | 3.2x | 7.2x | 9.1x |
| Total assets | $215M | $195M | $254M | $244M | $219M |
| Total liabilities | $40.4M | $24.9M | $57.5M | $28.5M | $20.6M |
| Shareholders' equity | $174M | $170M | $197M | $216M | $199M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 1 / 9 | 6 / 9 | 2 / 9 | 8 / 9 | 3 / 8 | 6 / 8 | 5 / 8 | 4 / 8 | 5 / 8 |
| Accruals ratio | 47.9% | โ11.7% | 202.8% | 5.5% | โ8.7% | 31.8% | โ3.8% | โ11.9% | 4.2% | โ8.7% |
| Altman Z'' | โ9.59 | โ12.32 | 14.49 | 1.84 | 14.35 | 11.98 | 13.11 | 10.07 | 15.08 | 16.02 |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $15.0M | $12.3M | $477M | $26.7M | $125M | $134M | $111M | $140M | $139M | $94.6M |
| Gross profit | $15.0M | $12.3M | $382M | $25.0M | $110M | $117M | $100M | $122M | $107M | $64.9M |
| Research and development | $19.7M | $16.7M | $13.0M | $13.3M | $10.9M | $9.9M | $22.5M | $16.4M | $12.3M | $20.0M |
| Operating income | โ$31.0M | โ$18.8M | $355M | โ$2.3M | $84.5M | $89.1M | $42.7M | $83.6M | $70.0M | $23.7M |
| Interest expense | $2.4M | $14.8M | $15.5M | $15.8M | $3.0M | $0.0M | $0.0M | โ | โ | โ |
| Pretax income | โ$39.7M | โ$38.3M | $412M | โ$10.2M | $73.5M | $89.3M | $44.1M | $87.8M | $76.1M | $30.4M |
| Income tax | $0.0M | โ$2.1M | โ$10.2M | โ$2.9M | $17.2M | $19.9M | $10.2M | $19.7M | $16.9M | $7.1M |
| Net income | โ$39.7M | โ$36.2M | $422M | โ$7.2M | $56.3M | $69.5M | $33.9M | $68.1M | $59.2M | $23.3M |
| Diluted EPS | โ$0.69 | โ$0.46 | $5.18 | โ$0.15 | $0.71 | $0.91 | $0.46 | $0.95 | $0.82 | $0.32 |
| Diluted shares | 0.06B | 0.08B | 0.08B | 0.08B | 0.08B | 0.08B | 0.07B | 0.07B | 0.07B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | โ$117M | โ$18.4M | $68.9M | โ$18.2M | $71.5M | $11.5M | $41.6M | $94.8M | $48.8M | $43.5M |
| Capital expenditure | $0.0M | $0.1M | $0.1M | $0.0M | โ | โ | โ | โ | โ | โ |
| Free cash flow | โ$117M | โ$18.5M | $68.8M | โ$18.2M | โ | โ | โ | โ | โ | โ |
| Depreciation and amortization | $0.2M | $0.1M | $0.1M | $0.5M | $0.5M | $0.5M | $0.5M | $0.5M | $0.5M | $0.6M |
| Stock-based compensation | $0.8M | $1.1M | $2.3M | $2.1M | $1.4M | $1.3M | $1.8M | $2.1M | $3.6M | $3.7M |
| Share buybacks | $0.0M | $0.1M | $0.0M | $0.0M | $28.5M | $26.0M | $13.0M | $11.1M | $0.0M | $0.0M |
| Dividends paid | โ | โ | โ | โ | $0.0M | $0.0M | $32.9M | $32.1M | $42.7M | $43.1M |
| Dividends and buybacks | $0.0M | $0.1M | $0.0M | $0.0M | $28.5M | $26.0M | $45.9M | $43.2M | $42.7M | $43.1M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $28.7M | $19.9M | $101M | $65.2M | $118M | $103M | $98.8M | $150M | $155M | $155M |
| Total debt | $66.6M | $71.1M | $75.5M | $80.0M | $0.0M | โ | โ | โ | โ | โ |
| Current assets | $69.2M | $37.4M | $121M | $180M | $144M | $209M | $186M | $239M | $231M | $213M |
| Current liabilities | $7.1M | $6.8M | $11.3M | $91.7M | $10.5M | $30.5M | $21.5M | $54.1M | $25.3M | $18.0M |
| Inventory | $26.2M | $3.0M | $2.9M | $9.7M | $20.3M | $19.5M | $39.3M | $64.2M | $49.6M | $49.1M |
| Property and equipment, net | $0.3M | $0.1M | $0.2M | $2.6M | $2.1M | $2.4M | $1.8M | $1.3M | $1.3M | $1.1M |
| Goodwill | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M |
| Total assets | $161M | $145M | $203M | $199M | $150M | $215M | $195M | $254M | $244M | $219M |
| Total liabilities | $448M | $468M | $101M | $101M | $20.0M | $40.4M | $24.9M | $57.5M | $28.5M | $20.6M |
| Shareholders' equity | โ$287M | โ$323M | $103M | $97.8M | $130M | $174M | $170M | $197M | $216M | $199M |
| Margins | ||||||||||
| Gross margin | 100.0% | 100.0% | 80.0% | 93.3% | 88.2% | 87.6% | 90.6% | 87.3% | 77.4% | 68.6% |
| Operating margin | โ206.9% | โ153.6% | 74.4% | โ8.7% | 67.6% | 66.7% | 38.5% | 59.8% | 50.4% | 25.1% |
| EBITDA margin | โ205.8% | โ152.6% | 74.5% | โ6.7% | 68.0% | 67.0% | 39.0% | 60.1% | 50.8% | 25.7% |
| Net margin | โ264.9% | โ295.3% | 88.4% | โ27.1% | 45.1% | 52.0% | 30.6% | 48.6% | 42.7% | 24.6% |
| FCF margin | โ779.6% | โ150.7% | 14.4% | โ68.2% | โ | โ | โ | โ | โ | โ |
| Returns | ||||||||||
| Return on capital | โ | โ | 456.4% | โ1.6% | 544.1% | โ | โ | โ | โ | โ |
| Return on capital employed | โ20.2% | โ13.7% | 184.8% | โ2.2% | 60.6% | 48.4% | 24.6% | 41.8% | 32.0% | 11.8% |
| Return on equity | โ | โ | โ | โ7.2% | 49.5% | 45.7% | 19.7% | 37.1% | 28.7% | 11.2% |
| Return on assets | โ24.7% | โ23.7% | 242.3% | โ3.6% | 32.3% | 38.1% | 16.5% | 30.3% | 23.7% | 10.0% |
| Return on tangible equity | โ | โ | 413.5% | โ7.5% | 43.7% | 40.0% | 20.0% | 34.7% | 27.6% | 11.8% |
| Growth | ||||||||||
| Revenue growth | โ | โ18.1% | 3,788.3% | โ94.4% | 367.3% | 7.0% | โ17.1% | 26.3% | โ0.9% | โ31.8% |
| Net income growth | โ | โ | โ | โ101.7% | โ | 23.3% | โ51.2% | 100.8% | โ13.0% | โ60.7% |
| EPS growth | โ | โ | โ | โ102.9% | โ | 28.2% | โ49.5% | 106.5% | โ13.7% | โ61.0% |
| FCF growth | โ | โ | โ | โ126.5% | โ | โ | โ | โ | โ | โ |
| Share count change | โ | 37.9% | 4.9% | โ0.6% | โ3.3% | โ3.8% | โ3.7% | โ2.5% | 0.3% | โ0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | โ | โ | โ0.1x | โ | โ1.4x | โ | โ | โ | โ | โ |
| Debt / equity | โ | โ | 0.7x | 0.8x | 0.0x | โ | โ | โ | โ | โ |
| Interest coverage | โ12.9x | โ1.3x | 22.9x | โ0.1x | 28.0x | โ | โ | โ | โ | โ |
| Current ratio | 9.7x | 5.5x | 10.7x | 2.0x | 13.7x | 6.8x | 8.6x | 4.4x | 9.1x | 11.8x |
| Quick ratio | 6.0x | 5.0x | 10.4x | 1.9x | 11.8x | 6.2x | 6.8x | 3.2x | 7.2x | 9.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.2% | 0.8% | 0.0% | 0.1% | โ | โ | โ | โ | โ | โ |
| Stock comp / revenue | 5.2% | 9.0% | 0.5% | 7.9% | 1.1% | 0.9% | 1.6% | 1.5% | 2.6% | 3.9% |
| Payouts / FCF | โ | โ | 0.0% | โ | โ | โ | โ | โ | โ | โ |
| Quality scores | ||||||||||
| Piotroski F-score | โ | 1.0 | 6.0 | 2.0 | 8.0 | 3.0 | 6.0 | 5.0 | 4.0 | 5.0 |
| Altman Z'' | โ9.6 | โ12.3 | 14.5 | 1.8 | 14.3 | 12.0 | 13.1 | 10.1 | 15.1 | 16.0 |
| Accruals ratio | 47.9% | โ11.7% | 202.8% | 5.5% | โ8.7% | 31.8% | โ3.8% | โ11.9% | 4.2% | โ8.7% |
Source: SEC EDGAR XBRL filings (CIK 0001010086). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
